Abu Dhabi Uses AI to Explore New Blood Cancer Treatments
How Abu Dhabi Is Using AI to Search for New Blood Cancer Treatments Scientists examine computer-generated molecular structures as AI-assisted tools help researchers identify and optimize potential drug candidates. Artificial intelligence is increasingly moving beyond chatbots and automation and into one of the world's most difficult scientific challenges: discovering new medicines. In Abu Dhabi, researchers at Insilico Medicine are using generative AI to help identify and design potential drug candidates for blood cancers, marking another step in the UAE's growing ambitions in biotechnology and advanced scientific research. Insilico Medicine's official announcement The research focuses on BTK-targeting PROTACs , a class of molecules designed to eliminate specific proteins inside cells rather than simply blocking their activity. BTK, or Bruton's tyrosine kinase, is an important protein involved in B-cell signaling and has been studied as a therapeutic target in seve...